This HTML5 document contains 170 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38386037
rdf:type
wikibase:Item
schema:description
2015年论文 2015年論文 artículu científicu espublizáu en 2015 2015年论文 artikel ilmiah artikulong pang-agham 2015年論文 наукова стаття, опублікована в березні 2015 2015年论文 vitskapeleg artikkel scientific article published on 18 March 2015 artykuł naukowy vetenskaplig artikel wissenschaftlicher Artikel naučni članak artigo científico научни чланак article científic vitenskapelig artikkel vědecký článek videnskabelig artikel научна статия 2015년 논문 2015年論文 artigo científico bài báo khoa học tudományos cikk επιστημονικό άρθρο scientific article published on 18 March 2015 2015年論文 บทความทางวิทยาศาสตร์ বৈজ্ঞানিক নিবন্ধ 2015年の論文 artikull shkencor teaduslik artikkel 2015年論文 2015年论文 vedecký článok article scientific מאמר מדעי article scientifique artigo científico 2015年论文 articolo scientifico wetenschappelijk artikel artículo científico articol științific სამეცნიერო სტატია 2015 nî lūn-bûn научни чланак bilimsel makale scientific article published on 18 March 2015 scienca artikolo мақолаи илмӣ tieteellinen artikkeli مقالة علمية نشرت في 18 مارس 2015 научная статья 2015年论文
p:P577
wds:Q38386037-A85E60D1-268B-4FB9-90AB-FE12FB1D2055
wdt:P577
2015-03-18T00:00:00Z
p:P2860
wds:Q38386037-FC612496-6F17-43CE-8158-CF7097D6E773 wds:Q38386037-CC1D4434-4B5D-4E64-9EBB-54D478037147 wds:Q38386037-D3DB0F5A-B0F0-4C3B-AB4A-722AFAA6E249 wds:Q38386037-BDD366F0-55AD-468A-9E37-CC8B43FD8843 wds:Q38386037-BF7231C6-D83C-4A11-8547-9FB437330575 wds:Q38386037-C416D655-3AEC-4309-B369-92B8ECA91AC1 wds:Q38386037-AFA5267E-02F3-4AB7-B51A-FBCCC0D035B7 wds:Q38386037-B00CBC84-D578-443C-AA62-CAB5B1B26720 wds:Q38386037-B5B89D9E-7A50-40BA-B6C5-F595D48FE2D1 wds:Q38386037-BB42750A-9B2B-4361-83D3-919D36B47398 wds:Q38386037-9563EA80-FD5B-42EE-9855-A5F18FC62EEF wds:Q38386037-AED4C318-CA29-413D-8A42-B013740DD7C5 wds:Q38386037-7EFB8630-877B-4B6B-B09C-4A9B2840CFFB wds:Q38386037-80B4C2ED-882B-491F-9D77-B79FC65B561D wds:Q38386037-8BCA6792-5436-47BC-8640-7E7781048D3B wds:Q38386037-7D286A31-AE1B-47DD-BD9E-27F31434310C wds:Q38386037-65E18B50-83D5-4C5B-B9B8-62303D2F9F33 wds:Q38386037-43CEB869-2844-4186-887C-684A2099BA14 wds:Q38386037-48470E90-8089-453F-9E07-BD577CD9E36B wds:Q38386037-51F0D55B-3C69-45E3-8611-00244F1C6CE9 wds:Q38386037-39A1FBD9-67EB-4382-9C9A-57388ABA8BFA wds:Q38386037-30A1BD8E-9582-48FC-9638-DF32441A5DCD wds:Q38386037-3157F459-5795-457E-8F64-633BE4B87760 wds:Q38386037-18E03031-09A7-4697-9AF8-1DB968134854 wds:Q38386037-01A401B7-A570-4D29-883E-02B416E7DE32
wdt:P2860
wd:Q38128352 wd:Q37576158 wd:Q38186853 wd:Q34639805 wd:Q36826988 wd:Q34638316 wd:Q34621721 wd:Q34610473 wd:Q86704865 wd:Q26822530 wd:Q33912177 wd:Q34579127 wd:Q36856816 wd:Q34936117 wd:Q34506115 wd:Q28131668 wd:Q57569718 wd:Q57570870 wd:Q77623043 wd:Q28307320 wd:Q64112087 wd:Q83112666 wd:Q36233720 wd:Q43582734 wd:Q36344267
p:P2093
wds:Q38386037-284ED84C-AE1D-4AC1-B4D0-660E4DDAAA82 wds:Q38386037-17F84117-CF1D-4522-8A1A-75E5D890CCC6 wds:Q38386037-6AA68402-0D7C-44F7-B6AC-93D75D5E187E wds:Q38386037-54AE9AB4-C52B-4832-AF3E-2D9A95B40B98 wds:Q38386037-7979AB75-4C2A-4A35-98E0-7596DDEDB5FC wds:Q38386037-70709468-F6E2-49F4-ACDC-BF387780E1BA wds:Q38386037-3E23BD58-217A-4B84-88A0-70E1EC93082B wds:Q38386037-BD65CEBE-3DD6-43F6-85EF-A79C96C95E95 wds:Q38386037-90BCDD60-B29D-42A7-8F22-4CCEA1EF46BA wds:Q38386037-DA73530E-D50A-4828-82A1-EE85FFB196A5 wds:Q38386037-CEC9EF3B-8E33-4C6A-8D1E-1EE7B9F74538 wds:Q38386037-EC21CBE9-7355-4A5D-B17A-EF6F38F7A0A6
wdt:P2093
Akihiko Matsumine Toru Hiruma Tsukasa Yonemoto Hideo Morioka Toshiyuki Kunisada Hideshi Sugiura Hiroaki Hiraga Takafumi Ueda Tadashi Hasegawa Nobuhito Araki Mitsuru Takahashi Akira Kawai
rdfs:label
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.
skos:prefLabel
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.
schema:name
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.
p:P50
wds:Q38386037-9EEF1A22-9EB2-40C6-83D7-3F05C4FB657D wds:Q38386037-0283775F-EF4D-4884-8DA2-D30979A49BBF
wdt:P50
wd:Q86968586 wd:Q88925476
p:P1476
wds:Q38386037-2C97BB96-5E1A-4DA6-B661-6A1C00F641FB
wdt:P1476
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
p:P304
wds:Q38386037-4239BDEB-76B7-4509-8D8F-AB203CC9C712
wdt:P304
406-416
p:P31
wds:Q38386037-218BA361-9E75-47DF-BE6D-91B39D7B35F0
wdt:P31
wd:Q13442814
p:P921
wds:Q38386037-1605FE18-9316-437E-9560-B2949A463B20
wdt:P921
wd:Q974135
p:P698
wds:Q38386037-73998A3A-788A-4CD6-B304-BE51BF290400
wdtn:P698
n9:25795406
wdt:P698
25795406
p:P1433
wds:Q38386037-3E738E3E-5FE5-4D44-99B4-26B5DA695EA3
wdt:P1433
wd:Q13747613
p:P433
wds:Q38386037-6E595409-45ED-4BF8-98E2-CDBB8E84BAB9
p:P478
wds:Q38386037-E5985BC4-33FD-41D4-B6C1-A8E4D8A57B54
wdt:P433
4
wdt:P478
16
p:P356
wds:Q38386037-328F09FB-5114-415D-A82C-D84EC6EA74D1
wdtn:P356
n10:S1470-2045(15)70098-7
wdt:P356
10.1016/S1470-2045(15)70098-7
p:P5875
wds:Q38386037-5045BD28-370A-4DC6-9741-F66E6823928A
wdt:P5875
273790847